Newsletter | January 2, 2026

01.02.26 -- Is Charisma An API?

SPONSOR

INDUSTRY INSIGHTS

The No-BS Guide To Pharmaceutical Manufacturing Execution Systems

Stop the cycle of paper-based errors and batch record delays. Learn how a modular, compliance-first manufacturing system accelerates validation, enables real-time traceability, and shortens release cycles.

A Pragmatic Approach To Developing A Rare Disease Drug

We are beginning to see a rise in the interest of developing “orphan drugs." Discover challenges and considerations associated with the expedited development and how to successfully work through them.

Manual CQV Vs. AI-Powered CQV

Still validating the manual way? With AI-powered CQV, you can reclaim hours lost to protocols and audit prep. What used to take weeks is now done in minutes.

FROM THE EDITOR

Is Charisma An API?

After nearly 20 years in the pharmaceutical industry, Samir Shah, director of regulatory CMC for medical products and combination products at AstraZeneca, knows how beneficial charisma can be for the pharmaceutical professional. That’s why he presented the topic at the 2025 RAPS Convergence.

INDUSTRY INSIGHTS CONTINUED

Effective Environmental Monitoring And Control In Pharma Operations

A structured contamination control strategy uses the Plan, Do, Study, Act model, focusing on EMPQ, meticulous planning, trend analysis, and continuous improvement with CAPA and change control.

Strengthen Pharmaceutical Supply Chains With A U.S.-Based CDMO

While certain ingredients require sourcing abroad, partnering with a U.S.-based company that owns its manufacturing assets allows for direct oversight of product quality and supply reliability.

Accelerating Manufacturing Digitalization With Low-Code Development

Find out how a low-code approach to MES systems delivers speed, flexibility, and compliance, empowering manufacturers to overcome bottlenecks and embrace digital transformation.

Advanced Therapy Manufacturers' Checklist For Cleanroom Project Success

Current advances in cell, gene, and tissue therapies require a rethinking of how—and where—cleanroom manufacturing facilities could be built, enabling more options for sponsor process control.

Science To Success: CMC Strategies That Drive Market Readiness

Explore how a scientifically grounded framework for early-phase CMC development, integrating QbD and proactive risk management, helps de-risk drug development.

Improving Sustainability Via Incineration Reduction And Solvent Recovery

Wastewater incineration reduction and solvent recovery are two sustainable process techniques that can be built into the drug manufacturing workflow to significantly reduce carbon emissions and waste.

Catalent Biologics Installs Labeling Machines To Meet Requirements

To accelerate COVID-19 vaccine production, a leading biologics contract manufacturer sought high-speed labeling machines that could be rapidly deployed.

Innovation For Subcutaneous Delivery Of Large-Volume Complex Biologics

Examine the key findings of a new wearable injector clinical trial, including its positive impact on patient experience and the broader benefits of wearable injectors for chronic disease management.

SOLUTIONS

Our Spokane Foreign Trade Zone (FTZ)

Equip Your Team With Expert Pharmaceutical Training

A New Standard In Virus Filtration For Enhanced Biopharmaceutical Safety

Your Global Partner In Pharmaceutical Contamination Control

HPLC/UHPLC Fingertight Fittings

Connect With Pharmaceutical Online: